Wescott Financial Advisory Group LLC Purchases Shares of 2,895 iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Wescott Financial Advisory Group LLC purchased a new stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 2,895 shares of the financial services provider’s stock, valued at approximately $483,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Dynamic Advisor Solutions LLC boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 8.7% in the 2nd quarter. Dynamic Advisor Solutions LLC now owns 5,430 shares of the financial services provider’s stock valued at $889,000 after purchasing an additional 433 shares during the last quarter. Blume Capital Management Inc. lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 9.8% during the 2nd quarter. Blume Capital Management Inc. now owns 53,939 shares of the financial services provider’s stock valued at $8,827,000 after acquiring an additional 4,793 shares in the last quarter. Investment Management of Virginia LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the 2nd quarter valued at $573,000. Mercer Global Advisors Inc. ADV lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 34.9% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 3,799 shares of the financial services provider’s stock valued at $622,000 after acquiring an additional 982 shares in the last quarter. Finally, Avantax Planning Partners Inc. lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 5.0% during the 2nd quarter. Avantax Planning Partners Inc. now owns 1,649 shares of the financial services provider’s stock valued at $270,000 after acquiring an additional 78 shares in the last quarter. Institutional investors own 71.40% of the company’s stock.

Shares of NASDAQ:IBB traded up $1.85 during midday trading on Wednesday, hitting $171.78. 118,222 shares of the company’s stock traded hands, compared to its average volume of 3,183,334. The firm’s fifty day moving average price is $168.51 and its two-hundred day moving average price is $159.13. iShares Nasdaq Biotechnology ETF has a twelve month low of $128.23 and a twelve month high of $177.37.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Why does the United States have a lingering trade deficit?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.